Analyst Ratings for GlaxoSmithKline (GSK) [Neutrals]

GSK Rating Summary

GSK Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GSK
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $45.50 (+4.4%) * Over Last 12-Mos
Rating Score: 1.8 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/4/2015 Morgan Stanley Downgrade Equalweight
(Overweight)
N/A
(N/A)
44.03 43.59 -1% Details
5/13/2015 UBS Downgrade Neutral
(Buy)
N/A
(N/A)
45.27 43.59 -3.71% Details
Like GSK Ratings? Also take a look at THRX, NVS, LGND, PFE

GSK Ratings News